• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强的P2X1受体Ca2+内流对人血小板功能反应的影响。

Effects of enhanced P2X1 receptor Ca2+ influx on functional responses in human platelets.

作者信息

Rolf Michael G, Mahaut-Smith Martyn P

机构信息

Department of Physiology, University of Cambridge, UK.

出版信息

Thromb Haemost. 2002 Sep;88(3):495-502.

PMID:12353081
Abstract

G-protein-coupled P2Y1 and P2Y12 receptors play key roles in platelet activation, however the importance of ionotropic P2X1 receptors remains unclear. Platelet P2X1 responses are highly labile in vitro, but were greatly enhanced by increasing [Ca2+]o in the range 1-10 mM. The P2X1 agonist alpha,beta-MeATP stimulated a shape change which saturated at peak [Ca2+]i of > or = 400 nM, without evidence for aggregation. The maximal P2X1-evoked transmission decrease was 82% of that obtained via P2Y1 receptors. alpha,beta-MeATP caused a disc to sphere transformation in virtually all platelets, but lacked the long processes produced by ADP. Following block of P2Y1 receptors with A3P5PS, co-stimulation with alpha,beta,-MeATP and ADP failed to induce aggregation despite the generation of peak [Ca2+]i responses similar to those stimulated via P2Y1 receptors. Therefore early, transient Ca2+ influx via P2X1 receptors can contribute to platelet activation by stimulating a significant morphological change, but does not readily synergise with P2Y12 receptors to support aggregation.

摘要

G蛋白偶联的P2Y1和P2Y12受体在血小板激活中起关键作用,然而离子型P2X1受体的重要性仍不清楚。血小板P2X1反应在体外高度不稳定,但在1-10 mM范围内增加细胞外钙离子浓度([Ca2+]o)时会大大增强。P2X1激动剂α,β-亚甲基ATP(alpha,beta-MeATP)刺激了一种形状变化,在细胞内钙离子峰值浓度([Ca2+]i)≥400 nM时达到饱和,且无聚集迹象。P2X1引发的最大传递减少量是通过P2Y1受体获得的最大传递减少量的82%。α,β-亚甲基ATP几乎使所有血小板发生盘状到球状的转变,但没有ADP产生的长突起。在用A3P5PS阻断P2Y1受体后,尽管产生的细胞内钙离子峰值反应与通过P2Y1受体刺激产生的反应相似,但α,β-亚甲基ATP和ADP共同刺激未能诱导聚集。因此,早期通过P2X1受体的短暂钙离子内流可通过刺激显著的形态变化促进血小板激活,但不易与P2Y12受体协同支持聚集。

相似文献

1
Effects of enhanced P2X1 receptor Ca2+ influx on functional responses in human platelets.增强的P2X1受体Ca2+内流对人血小板功能反应的影响。
Thromb Haemost. 2002 Sep;88(3):495-502.
2
No requirement of P2X1 purinoceptors for platelet aggregation.血小板聚集不需要P2X1嘌呤受体。
Eur J Pharmacol. 1999 May 21;372(3):305-9. doi: 10.1016/s0014-2999(99)00201-0.
3
Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP.用α,β-亚甲基三磷酸腺苷选择性激活P2X1嘌呤受体引起的血小板形状改变
Thromb Haemost. 2001 Feb;85(2):303-8.
4
Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.二磷酸腺苷(ADP)诱导血小板活化的分子基础。II. P2Y1受体介导ADP诱导的血小板细胞内钙动员和形态变化。
J Biol Chem. 1998 Jan 23;273(4):2030-4. doi: 10.1074/jbc.273.4.2030.
5
The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.新型苏拉明类似物NF864在低纳摩尔范围内有效选择性阻断人血小板中的P2X1受体。
Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):1-13. doi: 10.1007/s00210-005-1085-z. Epub 2005 Sep 13.
6
Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.通过P2X1受体的钙离子内流增强了P2Y1受体诱发的钙离子信号传导以及二磷酸腺苷诱发的血小板聚集。
Mol Pharmacol. 2014 Sep;86(3):243-51. doi: 10.1124/mol.114.092528. Epub 2014 Jun 12.
7
The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen.三磷酸腺苷(ATP)门控的P2X1离子通道作为血小板对胶原蛋白反应的正向调节因子。
Thromb Haemost. 2001 Nov;86(5):1264-71.
8
Secreted dense granule adenine nucleotides promote calcium influx and the maintenance of elevated cytosolic calcium levels in stimulated human platelets.分泌的致密颗粒腺嘌呤核苷酸促进钙内流,并维持受刺激的人血小板中升高的细胞溶质钙水平。
Thromb Haemost. 1999 Feb;81(2):286-92.
9
Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.人血小板嘌呤能受体的激动剂浓度依赖性差异反应性:嘌呤能P2Y1受体介导的体外聚集、解聚和形状变化反应的药理学和动力学研究
Platelets. 2003 Nov-Dec;14(7-8):445-62. doi: 10.1080/09537100310001612399.
10
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].通过用递增剂量的NF449 [4,4',4'',4'''-(羰基双(亚氨基-5,1,3-苯三基双-(羰基亚氨基)))四苯-1,3-二磺酸八钠盐]选择性或非选择性抑制血小板P2受体来抑制血小板功能和血栓形成。
J Pharmacol Exp Ther. 2005 Jul;314(1):232-43. doi: 10.1124/jpet.105.084673. Epub 2005 Mar 25.

引用本文的文献

1
Development of a P2X1-eYFP receptor knock-in mouse to track receptors in real time.开发一种 P2X1-eYFP 受体敲入小鼠,以实时追踪受体。
Purinergic Signal. 2019 Sep;15(3):397-402. doi: 10.1007/s11302-019-09666-1. Epub 2019 Jul 8.
2
P2X1 Receptors Amplify FcγRIIa-Induced Ca2+ Increases and Functional Responses in Human Platelets.P2X1 受体增强了 FcγRIIa 诱导的人血小板中的 Ca2+ 增加和功能反应。
Thromb Haemost. 2018 Feb;118(2):369-380. doi: 10.1160/TH17-07-0530. Epub 2018 Jan 29.
3
The P2X1 receptor and platelet function.P2X1 受体与血小板功能。
Purinergic Signal. 2011 Sep;7(3):341-56. doi: 10.1007/s11302-011-9224-0. Epub 2011 Mar 22.
4
Primary and secondary agonists can use P2X(1) receptors as a major pathway to increase intracellular Ca(2+) in the human platelet.一级和二级激动剂可将P2X(1)受体作为主要途径,以增加人血小板中的细胞内Ca(2+)。
J Thromb Haemost. 2007 May;5(5):910-7. doi: 10.1111/j.1538-7836.2007.02525.x. Epub 2007 Mar 14.
5
Molecular properties of P2X receptors.P2X受体的分子特性。
Pflugers Arch. 2006 Aug;452(5):486-500. doi: 10.1007/s00424-006-0073-6. Epub 2006 Apr 11.
6
The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.新型苏拉明类似物NF864在低纳摩尔范围内有效选择性阻断人血小板中的P2X1受体。
Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):1-13. doi: 10.1007/s00210-005-1085-z. Epub 2005 Sep 13.